Pitching Session
Innovation beyond Switzerland: a selection of start-ups/emerging companies from international delegations
Date: | April 23, 2024 |
Time: | 13:00-14:00 |
Room: | Montreal |
Pitch summary
During this exciting pitching session, we are thrilled to present ten innovative start-ups and emerging companies from around the world that are making significant strides in the field of life sciences. These companies are revolutionizing the landscape with their cutting-edge technologies and solutions across various sectors within the life sciences industry, showcasing innovation, entrepreneurship, and a shared commitment to advancing healthcare and improving patient outcomes worldwide.
- Velvio is developing groundbreaking therapeutics for neurodegeneration, with a focus on a rare disease called amyotrophic lateral sclerosis (ALS), offering hope to patients with unmet medical needs.
- Ciloa specializes in exosome-based delivery of therapeutic proteins, which can be applied in different fields like novel therapeutic antibodies, vectors and vaccines.
- GeNEWity is active in the field of cell and gene therapies, focusing on developing autologous thymus tissue.
- Aicloud is proposing AI-driven solutions to discover novel classes of therapeutics.
- Eyam Health’s next generation platforms are “pandemic ready” and can be customized to design and deliver vaccines and immunotherapeutics on demand.
- Myomar Molecular specializes in developing innovative diagnostics tools that enable early detection of muscle diseases, leading to improved patient outcomes and healthcare efficiency.
- Nimble Science’s single-use capsule enables passive sampling of small bowel luminal fluid for diagnostics.
- Syncrest have specialized in the rapid and cost-effective manufacturing of middle-molecular weight drugs.
- RIBOPRO is at the forefront of high-quality mRNA manufacturing, offering a range of services that enable mRNA therapy pioneers to develop the medicines of the future.
- PhosPrint is a laser bioprinter developer focusing on the highly precise and rapid delivery of cells and other bio-inks on the substrates of interest.
Pitching Companies
- Velvio (Germany/Munich) (Title: Accelerated Regeneration as Powerful Tool to Treat Neurodegeneration in ALS), presenter: Ulrich Bogdahn
- Ciloa (France) (Title: Adiponectin-exosomes paired with GLP-1R agonist enhance weight loss and fat clearance while preserving muscle mass), presenter: Robert Mamoun
- Genewity (Netherlands) (Title: i-Thymus: autologous thymic organoids for curing immune deficiencies and more.), presenter: Arno Bisschop
- Aicloud (South Korea) (Title: AI-based K-antibody Design Technology), presenter: Cho Toohyon
- Eyam Health (Canada) (Title: Platform for vaccines and Immunotherapeutics), presenter: Pamela Housh
- Myomar Molecular (Canada) (Title: Monitoring Muscle Degeneration using Urine Biomarkers), presenter: Rafaela Andrade
- Nimble Science (Canada) (Title: Reaching the Unreachable: Leveraging Small Intestinal Data to Power Health Innovation), presenter: Sabina Brühlmann
- Syncrest (Japan) (Title: SynCrest Innovations: Leading the Future of Sustainable Chemical and Pharmaceutical Manufacturing with Advanced Flow Chemistry and In-Line Real-Time Monitoring), presenter: Yutaro ODA
- RIBOPRO (Netherlands) (Title: Manufacturing for high quality mRNA and LNPs), presenter: TBC
- PhosPrint (Greece) (Title: Tissue transformation via in vivo laser bioprinting), presenter: Maria Pallidou
Jury Members
- Zoë Johnson, M:M Bio
-
Kostas Kaloulis, ND Capital
- Natalia Novac, Delin Ventures
- Andi Dyla, Roivant Sciences
- András Incze, Akceso Advisors
Moderation
-
Maximilien Murone, Swiss Biotech Association